539470 — Shree Ganesh Bio-Tech (India) Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousMicro CapSucker Stock

Annual income statement for Shree Ganesh Bio-Tech (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	726	625	203	230	49.7
Cost of Revenue
Gross Profit	38.1	28.3	2.46	3.17	-0.853
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	692	603	205	240	59.3
Operating Profit	34.5	21.5	-2.01	-10.5	-9.58
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	35	27.1	8.55	3.87	5.14
Provision for Income Taxes
Net Income After Taxes	25.3	20.4	6.21	2.78	3.78
Net Income Before Extraordinary Items
Net Income	25.3	20.4	6.21	2.78	3.78
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	25.3	20.4	6.21	2.78	3.78
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.066	0.051	0.016	0.008	0.01